Joseph Zakar, PHARM D in Pebble Beach, CA - Pharmacist

Joseph Zakar, PHARM D is a Pharmacist - Ambulatory Care based in Pebble Beach, California. Joseph Zakar is licensed to practice in California (license number 27227) and his current practice location is 1010 Rodeo Rd, Pebble Beach, California. He can be reached at his office (for appointments etc.) via phone at (831) 642-9339.

NPI number for Joseph Zakar is 1417306176 and his current mailing address is Po Box 1729, Pebble Beach, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1417306176.

Contact Information

	Joseph Zakar, PHARM D
	1010 Rodeo Rd, Pebble Beach, CA 93953-2721
	(831) 642-9339
	(831) 646-1133

Healthcare Provider's Profile

Full Name	Joseph Zakar
Gender	Male
Speciality	Pharmacist - Ambulatory Care
Location	1010 Rodeo Rd, Pebble Beach, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1417306176
Provider Enumeration Date: 06/03/2016
Last Update Date: 06/03/2016

Medical Identifiers

Medical identifiers for Joseph Zakar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417306176	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1835P2201X	Pharmacist - Ambulatory Care	27227 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joseph Zakar is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Joseph Zakar, PHARM D Po Box 1729, Pebble Beach, CA 93953-1729 Ph: (831) 642-9339	Joseph Zakar, PHARM D 1010 Rodeo Rd, Pebble Beach, CA 93953-2721 Ph: (831) 642-9339

News Archive

New rotavirus vaccines could reduce mortality from the disease by up to 60 percent

Health officials from 16 countries today asked for budgetary support "to ensure the sustainability of the existing vaccination programs and the introduction of new vaccines," at the conclusion of a global symposium on rotavirus, a diarrheal disease that kills over 600,000 children worldwide every year.

EC grants European market authorization for Revestive to treat short bowel syndrome

Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.

Standard decontamination technologies can remove or inactivate all viruses from drinking water

Among the many avenues that viruses can use to infect humans, drinking water may pose only a tiny risk for spreading certain viruses like the novel coronavirus.

Evidence could prove that humans have unique cortical brain networks

Our ancestors evolutionarily split from those of rhesus monkeys about 25 million years ago. Since then, brain areas have been added, have disappeared or have changed in function. This raises the question, 'Has evolution given humans unique brain structures?'. Scientists have entertained the idea before but conclusive evidence was lacking. By combining different research methods, we now have a first piece of evidence that could prove that humans have unique cortical brain networks.

90 million Africans with AIDS predicted

In a study, entitled Aids in Africa, compiled over two years, using over 150 experts, the UN predicts that nearly 90 million Africans could be infected in the next 20 years if the epidemic is not combated. Some 25 million Africans have HIV.

Joseph Zakar, PHARM D - Pharmacist in Pebble Beach, CA